Identification of gestational diabetes mellitus in European electronic healthcare databases: insights from the ConcePTION project
Year: 2025
Type: article
Study design: Observational Study
Abstract: Objective To develop and compare algorithms for identifying gestational diabetes mellitus (GDM) across European electronic healthcare databases and evaluate their impact on the estimated prevalence. Design Multi-national cohort study using routinely collected electronic healthcare data Setting National and regional databases in five European countries (Norway, Finland, Italy, Spain and France), in primary and/or secondary care. Participants Pregnancy cohorts resulting in stillbirths or live births between 2009 and 2020, comprising 602 897 pregnancies in Norway, 507 904 in Finland, 374 009 in Italy, 193 495 in Spain and 116 762 in France. Primary and secondary outcomes The primary outcome was the prevalence of GDM identified using six algorithms: (1) Only diagnosis; (2) Diagnosis or prescription; (3) Two diagnoses or prescriptions ( 2DxRx ); (4) Diagnosis including unspecified diabetes in pregnancy or prescription ( DxRx broad ); (5) Diagnosis excluding pre-existing diabetes in pregnancy or prescription; (6) Registration of GDM in a birth registry ( BR ). Results The strictest algorithm ( 2DxRx ) resulted in the lowest GDM prevalence, while the broadest ( DxRx broad ) resulted in the highest, except in France where it was BR . In the Nordic countries, GDM prevalence varied only slightly by algorithm; greater variations were observed in other countries. The prevalence ranged from 3.5% (95% CI: 3.5% to 3.5%) to 4.6% (95% CI: 4.5% to 4.7%) in Norway; 12.1% (95% CI: 12.0% to 12.2%) to 15.8% (95% CI: 15.7% to 15.9%) in Finland, where prevalence was much higher than elsewhere. The prevalence ranged from 1.3% (95% CI: 1.3% to 1.3%) to 5.4% (95% CI: 5.3% to 5.5%) in Italy; 1.6% (95% CI: 1.5% to 1.7%) to 6.2% (95% CI: 6.1% to 6.3%) in Spain; and 1.7% (95% CI: 1.6% to 1.8%) to 5.8% (95% CI: 5.7% to 5.9%) in France. Conclusions In this multinational study, GDM prevalence ranged from 1.3% to 15.8% depending on the algorithm and database. Nordic countries showed smaller differences in prevalence between algorithms, while the other countries showed larger variations, likely due to differences in coding practices, healthcare systems and database coverage.
Source: BMJ Open
Authors: Ditte Mølgaard-Nielsen, Vera Mitter, Angela Lupattelli, Vjola Hoxhaj, Constanza L Andaur Navarro, Saeed Hayati, Sandra Lopez-Leon, Joan K Morris, Anja Geldof, Susan Jordan, Maarit K Leinonen, Visa Martikainen, Marco Manfrini, Luca Cammarota, Amanda Neville, Laia Barrachina-Bonet, Clara Cavero-Carbonell, Laura García-Villodre, Anthony Caillet, Marie Beslay, Christine Damase-Michel, Marleen M H J van Gelder, Hedvig Nordeng
Institutions: Novo Nordisk (Denmark), Bern University of Applied Sciences, University of Oslo, Utrecht University, Rutgers, The State University of New Jersey, Novartis (United States), University of London, Janssen (Netherlands), Swansea University, Finnish Institute for Health and Welfare, University of Ferrara, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, Université de Toulouse, Norwegian Institute of Public Health
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,839
OpenAlex ID: W4414841015
